These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15977684)

  • 1. Streptococcus pneumoniae serotypes/serogroups causing invasive disease in Riyadh, Saudi Arabia: extent of coverage by pneumococcal vaccines.
    Al-Mazrou A; Twum-Danso K; Al Zamil F; Kambal A
    Ann Saudi Med; 2005; 25(2):94-9. PubMed ID: 15977684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage.
    Watson M; Bayley K; Bell JM; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Roche P; Smith HV; Stewart MG; Stylianopoulos J; Turnidge J
    Commun Dis Intell Q Rep; 2003; 27(4):478-87. PubMed ID: 15508501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the introduction of pneumococcal conjugate vaccines on serotype prevalence in Kuwait and Saudi Arabia.
    Mokaddas EM; Shibl AM; Elgouhary A; Elsobky M
    Vaccine; 2018 Oct; 36(43):6442-6448. PubMed ID: 30194003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penicillin resistance in serogroups/serotypes of Streptococcus pneumoniae causing invasive infections in Central Saudi Arabia.
    Twum-Danso K; Al-Mazrou AM; Kambal AM; Al-Zamil FA
    Saudi Med J; 2003 Nov; 24(11):1210-3. PubMed ID: 14647555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive pneumococcal diseases in Uruguayan children: comparison between serotype distribution and conjugate vaccine formulations.
    Camou T; Palacio R; Di Fabio JL; Hortal M
    Vaccine; 2003 May; 21(17-18):2093-6. PubMed ID: 12706699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
    Shibl AM; Memish ZA; Al-Kattan KM
    Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of Streptococcus pneumoniae penicillin resistance and serotype distribution in Kuwait for disease treatment and prevention.
    Mokaddas EM; Rotimi VO; Albert MJ
    Clin Vaccine Immunol; 2008 Feb; 15(2):203-7. PubMed ID: 18077618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumococcal serogroups and serotypes in severe pneumococcal pneumonia in Belgian children: theoretical coverage of the 7-valent and 9-valent pneumococcal conjugate vaccines.
    De Schutter I; Malfroot A; Piérard D; Lauwers S
    Pediatr Pulmonol; 2006 Aug; 41(8):765-70. PubMed ID: 16779850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates from 17 Chinese cities from 2011 to 2016.
    Zhao C; Li Z; Zhang F; Zhang X; Ji P; Zeng J; Hu B; Hu Z; Liao K; Sun H; Zhang R; Cao B; Zhuo C; Jia W; Mei Y; Chu Y; Xu X; Yang Q; Jin Y; Fu Q; Xu X; Li H; Wang L; Ni Y; Liang H; Wang H
    BMC Infect Dis; 2017 Dec; 17(1):804. PubMed ID: 29284419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: a 10-year study.
    Charfi F; Smaoui H; Kechrid A
    Vaccine; 2012 Dec; 30 Suppl 6():G18-24. PubMed ID: 23228353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotype distribution of Streptococcus pneumoniae isolated from children hospitalized in Beijing children's hospital (2013-2019).
    Wang Q; Shi W; Li Y; Gao W; Yuan L; Dong F; Yao K
    Vaccine; 2020 Nov; 38(49):7858-7864. PubMed ID: 33164807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal serotype evolution in Western Europe.
    Tin Tin Htar M; Christopoulou D; Schmitt HJ
    BMC Infect Dis; 2015 Oct; 15():419. PubMed ID: 26468008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
    Isaacman DJ; McIntosh ED; Reinert RR
    Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.
    Kaplan SL; Mason EO; Wald ER; Schutze GE; Bradley JS; Tan TQ; Hoffman JA; Givner LB; Yogev R; Barson WJ
    Pediatrics; 2004 Mar; 113(3 Pt 1):443-9. PubMed ID: 14993532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain reaction-based surveillance: an experience from South Africa.
    Tempia S; Wolter N; Cohen C; Walaza S; von Mollendorf C; Cohen AL; Moyes J; de Gouveia L; Nzenze S; Treurnicht F; Venter M; Groome MJ; Madhi SA; von Gottberg A
    BMC Infect Dis; 2015 Oct; 15():450. PubMed ID: 26496761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Streptococcus pneumoniae serotype distribution in Vojvodina before the introduction of pneumococcal conjugate vaccines into the National Immunization Program.
    Petrović V; Šeguljev Z; Ristić M; Djekić-Malbaša J; Radosavljević B; Medić D; Mihajlović-Ukropina M; Hadnadjev M; Gajic I; Opavski N
    Srp Arh Celok Lek; 2016; 144(9-10):521-6. PubMed ID: 29653038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine.
    Gonzalez BE; Hulten KG; Lamberth L; Kaplan SL; Mason EO;
    Pediatr Infect Dis J; 2006 Apr; 25(4):301-5. PubMed ID: 16567980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-year surveillance of invasive Streptococcus pneumoniae isolates in central Turkey prior to the introduction of a conjugate vaccine.
    Percin D; Ay Altintop Y; Sumerkan B
    J Infect Dev Ctries; 2010 Oct; 4(9):560-5. PubMed ID: 21045368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The direct effect of pneumococcal conjugate vaccines on invasive pneumococcal disease in children in the Latin American and Caribbean region (SIREVA 2006-17): a multicentre, retrospective observational study.
    Agudelo CI; Castañeda-Orjuela C; Brandileone MCC; Echániz-Aviles G; Almeida SCG; Carnalla-Barajas MN; Regueira M; Fossati S; Alarcón P; Araya P; Duarte C; Sánchez J; Novas M; Toraño-Peraza G; Rodríguez-Ortega M; Chamorro-Cortesi G; Kawabata A; García-Gabarrot G; Camou T; Spadola E; Payares D; Andrade AL; Di Fabio JL; Castañeda E;
    Lancet Infect Dis; 2021 Mar; 21(3):405-417. PubMed ID: 32986996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.